Clinical Characteristics, Patient-Reported Outcomes, and Previous Therapeutic Management of Patients with Uncontrolled Neuropathic Pain Referred to Pain Clinics

Table 5

Most common (≥5%) drugs for the treatment of neuropathic pain at the time of referral.

Drug	% patients	Mean dose (SD) mg/day	Duration (months) mean (SD)
Paracetamol	21.2	2,398.6 (960.1)	5.5 (6.3)
NSAIDs
Ibuprofen	17.9	1,428.4 (457.2)	8.5 (13.3)
Metamizol	14.8	2,158.8 (1,598.7)	8.5 (13.3)
Diclofenac	6.3	124.9 (34.8)	8.5 (13.3)
Opiods
Tramadol	27.1	182.9 (110.1)	12.1 (21.5)
Fentanil	8.6	18.5 (25.1)	7.5 (12.9)
AED
Pragabalin	27.2	244.6 (242.5)	13.8 (17.4)
Gabapentin	19.0	1,297.7 (646.9)	9.3 (12.0)
Carbamazepine	5.1	577.1 (313.5)	22.2 (27.5)
Antidepressants
Amitriptyline	10.8	36.2 (27.3)	12.9 (15.4)
Duloxetine	6.1	58.3 (22.0)	8.1 (8.0)
Other drugs
Clonazepam	5.7	2.1 (2.7)	2.2 (1.0)

SD: standard deviation.